Plain-English translation of NCT06967727 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a registry study—meaning researchers are collecting and organizing medical information and genetic data from people who have both epilepsy (seizures) and movement disorders (like involuntary movements or difficulty controlling muscles). By gathering information from many people with these conditions, researchers hope to understand why some people develop both disorders together, which genes are involved, and how these conditions affect people over time.
Doctors and researchers have noticed that some children and adults experience both seizures and unusual movement problems at the same time, but these "epilepsy-dyskinesia syndromes" remain poorly understood. Over 100 different genes have been linked to these conditions, yet much remains unknown about how they work and how to best treat them. This study aims to close that knowledge gap by collecting real-world information from patients.
You likely qualify if…
You likely don't qualify if…
Participation in this registry means sharing your medical records, genetic test results, and information about your symptoms and diagnosis history with the research team. You may be asked to provide updates about your health over time. This is not a treatment study—researchers are simply gathering and organizing information to better understand these conditions, so there are no medications or procedures involved in the study itself.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
United States
Sponsor
Boston Children's Hospital
Enrollment target
~700 participants
Started
June 2025
Primary completion
June 2030
Age range
0 Years – 30 Years
Last updated on clinicaltrials.gov in August 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Darius Ebrahimi-Fakhari, MD, PhD
Boston Children's Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.